These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Genetic Exchange of Lung-Derived Exosome to Brain Causing Neuronal Changes on COVID-19 Infection. Ahmed SSSJ; Paramasivam P; Kamath M; Sharma A; Rome S; Murugesan R Mol Neurobiol; 2021 Oct; 58(10):5356-5368. PubMed ID: 34312772 [TBL] [Abstract][Full Text] [Related]
4. Meta-analysis of the serum/plasma proteome identifies significant associations between COVID-19 with Alzheimer's/Parkinson's diseases. Mahin A; Soman SP; Modi PK; Raju R; Keshava Prasad TS; Abhinand CS J Neurovirol; 2024 Feb; 30(1):57-70. PubMed ID: 38167982 [TBL] [Abstract][Full Text] [Related]
5. The Influence of Coronavirus Disease-2019 (COVID-19) On Parkinson's Disease: An Updated Systematic Review. Jaiswal V; Alquraish D; Sarfraz Z; Sarfraz A; Nagpal S; Singh Shrestha P; Mukherjee D; Guntipalli P; Sánchez Velazco DF; Bhatnagar A; Savani S; Halilaj E; Ruxmohan S; Cueva W J Prim Care Community Health; 2021; 12():21501327211039709. PubMed ID: 34404266 [TBL] [Abstract][Full Text] [Related]
6. Protein-driven mechanism of multiorgan damage in COVID-19. Estrada E Med Drug Discov; 2020 Oct; ():100069. PubMed ID: 33103107 [TBL] [Abstract][Full Text] [Related]
7. Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. Stukalov A; Girault V; Grass V; Karayel O; Bergant V; Urban C; Haas DA; Huang Y; Oubraham L; Wang A; Hamad MS; Piras A; Hansen FM; Tanzer MC; Paron I; Zinzula L; Engleitner T; Reinecke M; Lavacca TM; Ehmann R; Wölfel R; Jores J; Kuster B; Protzer U; Rad R; Ziebuhr J; Thiel V; Scaturro P; Mann M; Pichlmair A Nature; 2021 Jun; 594(7862):246-252. PubMed ID: 33845483 [TBL] [Abstract][Full Text] [Related]
8. Is COVID-19 a Perfect Storm for Parkinson's Disease? Brundin P; Nath A; Beckham JD Trends Neurosci; 2020 Dec; 43(12):931-933. PubMed ID: 33158605 [TBL] [Abstract][Full Text] [Related]
9. Covid-19 and Parkinson's disease: Acute clinical implications, long-COVID and post-COVID-19 parkinsonism. Leta V; Boura I; van Wamelen DJ; Rodriguez-Violante M; Antonini A; Chaudhuri KR Int Rev Neurobiol; 2022; 165():63-89. PubMed ID: 36208907 [TBL] [Abstract][Full Text] [Related]
10. Proteomic and phosphoproteomic characteristics of the cortex, hippocampus, thalamus, lung, and kidney in COVID-19-infected female K18-hACE2 mice. Liu JF; Peng WJ; Wu Y; Yang YH; Wu SF; Liu DP; Liu JN; Yang JT EBioMedicine; 2023 Apr; 90():104518. PubMed ID: 36933413 [TBL] [Abstract][Full Text] [Related]
11. Does SARS-CoV-2 affect neurodegenerative disorders? TLR2, a potential receptor for SARS-CoV-2 in the CNS. Szabo MP; Iba M; Nath A; Masliah E; Kim C Exp Mol Med; 2022 Apr; 54(4):447-454. PubMed ID: 35396576 [TBL] [Abstract][Full Text] [Related]
12. The roles of Eph receptors, neuropilin-1, P2X7, and CD147 in COVID-19-associated neurodegenerative diseases: inflammasome and JaK inhibitors as potential promising therapies. Zalpoor H; Akbari A; Samei A; Forghaniesfidvajani R; Kamali M; Afzalnia A; Manshouri S; Heidari F; Pornour M; Khoshmirsafa M; Aazami H; Seif F Cell Mol Biol Lett; 2022 Feb; 27(1):10. PubMed ID: 35109786 [TBL] [Abstract][Full Text] [Related]
13. Encephalitic syndrome and anosmia in COVID-19: Do these clinical presentations really reflect SARS-CoV-2 neurotropism? A theory based on the review of 25 COVID-19 cases. Pouga L J Med Virol; 2021 Jan; 93(1):550-558. PubMed ID: 32672843 [TBL] [Abstract][Full Text] [Related]
14. Parkinson's disease following COVID-19: causal link or chance occurrence? Li WS; Chan LL; Chao YX; Tan EK J Transl Med; 2020 Dec; 18(1):493. PubMed ID: 33375935 [No Abstract] [Full Text] [Related]
15. Favourable course in a cohort of Parkinson's disease patients infected by SARS-CoV-2: a single-centre experience. Buccafusca M; Micali C; Autunno M; Versace AG; Nunnari G; Musumeci O Neurol Sci; 2021 Mar; 42(3):811-816. PubMed ID: 33439387 [TBL] [Abstract][Full Text] [Related]
16. Viruses, parkinsonism and Parkinson's disease: the past, present and future. Leta V; Urso D; Batzu L; Lau YH; Mathew D; Boura I; Raeder V; Falup-Pecurariu C; van Wamelen D; Ray Chaudhuri K J Neural Transm (Vienna); 2022 Sep; 129(9):1119-1132. PubMed ID: 36036863 [TBL] [Abstract][Full Text] [Related]
18. Prevalence and impact of COVID-19 in Parkinson's disease: evidence from a multi-center survey in Tuscany region. Del Prete E; Francesconi A; Palermo G; Mazzucchi S; Frosini D; Morganti R; Coleschi P; Raglione LM; Vanni P; Ramat S; Novelli A; Napolitano A; Battisti C; Giuntini M; Rossi C; Menichetti C; Ulivelli M; De Franco V; Rossi S; Bonuccelli U; Ceravolo R; J Neurol; 2021 Apr; 268(4):1179-1187. PubMed ID: 32880722 [TBL] [Abstract][Full Text] [Related]
19. CNS tau efflux via exosomes is likely increased in Parkinson's disease but not in Alzheimer's disease. Shi M; Kovac A; Korff A; Cook TJ; Ginghina C; Bullock KM; Yang L; Stewart T; Zheng D; Aro P; Atik A; Kerr KF; Zabetian CP; Peskind ER; Hu SC; Quinn JF; Galasko DR; Montine TJ; Banks WA; Zhang J Alzheimers Dement; 2016 Nov; 12(11):1125-1131. PubMed ID: 27234211 [TBL] [Abstract][Full Text] [Related]
20. Exploring the relationship between novel Coronavirus pneumonia and Parkinson's disease. Xi X; Han L Medicine (Baltimore); 2022 Nov; 101(46):e31813. PubMed ID: 36401405 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]